Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The New Ketone Alphabet Soup: BHB, HCA, and HDAC.

Literature DB >> 25678874

The New Ketone Alphabet Soup: BHB, HCA, and HDAC.

Adam L Hartman, Jong M Rho.

Abstract

Entities: Chemical

Year: 2014 PMID： 25678874 PMCID： PMC4325597 DOI： 10.5698/1535-7597-14.6.355

Source DB: PubMed Journal: Epilepsy Curr ISSN： 1535-7511 Impact factor: 7.500

× No keyword cloud information.

20 in total

1. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen.

Authors: C J Phiel; F Zhang; E Y Huang; M G Guenther; M A Lazar; P S Klein
Journal: J Biol Chem Date: 2001-07-25 Impact factor: 5.157

2. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES).

Authors: Rima Nabbout; Michel Mazzuca; Philippe Hubert; Sylviane Peudennier; Catherine Allaire; Vincent Flurin; Marina Aberastury; Walter Silva; Olivier Dulac
Journal: Epilepsia Date: 2010-08-31 Impact factor: 5.864

3. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid.

Authors: J D Morrow; W G Parsons; L J Roberts
Journal: Prostaglandins Date: 1989-08

Review 4. Neuroprotection in metabolism-based therapy.

Authors: Adam L Hartman
Journal: Epilepsy Res Date: 2011-08-26 Impact factor: 3.045

5. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors: Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal: Science Date: 2012-12-06 Impact factor: 47.728

Review 6. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.

Authors: Aleksey G Kazantsev; Leslie M Thompson
Journal: Nat Rev Drug Discov Date: 2008-10 Impact factor: 84.694

7. Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury.

Authors: Hidetoshi Taniguchi; Ikuko Mohri; Hitomi Okabe-Arahori; Kosuke Aritake; Kazuko Wada; Takahisa Kanekiyo; Shuh Narumiya; Masahiro Nakayama; Keiichi Ozono; Yoshihiro Urade; Masako Taniike
Journal: J Neurosci Date: 2007-04-18 Impact factor: 6.167

The New Ketone Alphabet Soup: BHB, HCA, and HDAC.

1. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen.

2. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES).

3. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid.

Review 4. Neuroprotection in metabolism-based therapy.

5. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Review 6. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.

7. Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury.

Review 8. Energy failure: does it contribute to neurodegeneration?

Review 9. Ketogenic diets: evidence for short- and long-term efficacy.

10. Metabolic control of vesicular glutamate transport and release.

1. RNA sequencing reveals niche gene expression effects of beta-hydroxybutyrate in primary myotubes.

Review 2. Ketogenic diet, neuroprotection, and antiepileptogenesis.

Review 3. Beta-Hydroxybutyrate: A Dual Function Molecular and Immunological Barrier Function Regulator.

Review 4. The Evolution of Ketosis: Potential Impact on Clinical Conditions.